Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide ...

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide ...

The platform's library of specialised life sciences agents creates an adaptable framework that breaks down silos between data ...

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

The new data – from the ARISE trial – found that Cobenfy wasn't statistically better than placebo at improving the widely ...

PE-backed specialty pharma company Kelso Pharma, which recently acquired Italian medical device and pharma company Velit ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr, who oversees the FDA, has made no secret of his desire to ban ...

Shares in Eli Lilly rose sharply in pre-market trading today after the company reported the first phase 3 results for orforglipron, a GLP-1 agonist that it hopes will offer an oral alternative to ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an additional 38% considered overweight. This epidemic not only impacts individual ...

President Trump's tariffs on goods coming into the US from Europe, China, and Canada could have a profound and damaging impact on the biopharma sector. That's the conclusion of a survey carried ...

MoonLake Immunotherapeutics has secured up to $500 million in non-dilutive financing from Hercules Capital, bolstering its cash reserves as it ushers its lead drug for inflammatory diseases ...

After 15 years as the PM Society Digital Awards, and after taking feedback from our membership, this successful event has evolved its name and sharpened its focus on impact and innovation.